Thomas J. Miller
31 Pond View Lane
Concord, MA 01742
+1 (978) 289-0774
tmiller@greybirdventures.com
Education
1979:
University of Massachusetts at Lowell
BS in Nuclear Engineering cum laude
1982:
Massachusetts Institute of Technology / Harvard Medical School
SM in Medical Physics from the Joint Program in Health Sciences and Technology
Work Experience
1979:
Research Fellow, Massachusetts General Hospital, Boston, MA
Department of Radiation Biophysics. Developed radiation therapy
planning program for the treatment of retinal melanoma with a beam of protons.
1981:
Research Fellow, Brookhaven National Laboratory, Brookhaven, NY
National Synchrotron Light Source. Developed apparatus for molecular biology.
1982:
CT Product Specialist, Siemens Medical Systems, Inc., Iselin, NJ
Thereafter, promoted to positions of increasing responsibility in sales and marketing.
1988:
Division Vice President, Siemens Medical Systems, Inc., Iselin, NJ
Responsible for all magnetic resonance imaging activities in the USA including sales,
marketing, service, applications, R&D, finance and administration.
1992:
MR Division General Manager, Siemens AG, Erlangen, Germany
Responsible for the worldwide magnetic resonance business for Siemens.
1995:
Group VP, Imaging Systems, Siemens Medical Systems, Inc., Iselin, NJ
Responsible for American operations for medical imaging and elected
officer of Siemens Medical Systems, Inc.
1997:
President and Chief Executive Officer, Carl Zeiss, Inc., Thornwood, NY
Responsible for all of the activities of Carl Zeiss in North America.
1
Work Experience (continued)
1998:
General Manager of Carl Zeiss Medical Group, Oberkochen, Germany
Responsible for global activities of Carl Zeiss in health care while simultaneously
CEO of Carl Zeiss, Inc. USA.
1999:
Chairman, LightLab Imaging, LLC, Westford, MA
Co-founded start-up for new technology of OCT (Optical Coherence Tomography).
1999:
Member of Executive Management Group, Carl Zeiss, Oberkochen, Germany
Received additional responsibilities for management of various global operating
companies within the Carl Zeiss Group.
1999:
President, COO, and Director, Analogic Corporation, Peabody, MA
Responsible for operations of this NASDAQ Corporation.
2001:
President, Chief Executive Officer, and Director, Analogic Corporation
Promoted by the Board of Directors to CEO.
2001:
Director, Photoelectron Corporation, Lexington, MA
Member of the Board of this NASDAQ listed company sold to Carl Zeiss in 2002.
2001:
Director, Cedara Software, Toronto, Canada
NASDAQ listed company develops software for the medical imaging industry
2002:
Chairman and CEO, LightLab Imaging, LLC, Westford, MA
Assumed operational control to sell the company. Sale completed in 5 months.
2002:
Vice President, Business Development, Siemens AG, UB Med, Erlangen, Germany
Responsible for M&A, corporate business strategy, and innovation management.
2003:
CEO, Siemens Medical Solutions, Inc., Health Services, Malvern, PA
Responsibility for global healthcare IT business (Shared Medical) acquired by
Siemens in 2000.
2005:
Member of the Managing Board, Siemens AG, Healthcare, Erlangen, Germany
Responsible for various global business units, geographies, and staff functions.
2007:
CEO, Customer Solutions Division, Siemens AG, Healthcare, Erlangen, Germany
Responsible for all downstream activities (26,000 employees in over 130 countries)
for Siemens Healthcare as well as new services and IT businesses.
2013:
Founder, GreyBird Ventures, Concord, MA
Umbrella company for various independent consulting, investment, and management
activities.
2
Major Business Accomplishments
Vice President/Division Manager, SMS MR Division (Sales - $280M):
Turned first operating profit within 18 months. Subsequently, this Division went from fourth largest
and loss leader to the largest and most profitable in the USA. Then appointed General Manager of
the global MR Division at the age of 34, the youngest GM and first non-German to run a Germanybased global business.
General Manager, Siemens AG, UB Med, MR Division (Sales - DM 1.1B):
Turned first operating profit within 13 months. In 1994, the Siemens MR Division became the most
profitable division in the Medical Group and passed General Electric as world market leader.
Group Vice President, Imaging Systems, Siemens Medical Systems, Inc. (Sales - $800M):
Reversed four year running revenue and profit decline within first 12 months. Started two new
service businesses (Managed Healthcare Services and Integrated Service Management) both of which
generated operating profits in their first year.
President and CEO of Carl Zeiss, Inc (Sales - $300M):
After over five continuous years of losses, in 1999 Carl Zeiss, Inc. generated a profit of 5% on sales
through drastic restructuring of sales channels and elimination of marginal unprofitable businesses.
General Manager of the Medical Division of Carl Zeiss (Sales - DM 800M):
Restructured the businesses globally and started two new companies to fuel growth. In FY 1997 this
division generated a 1% return on sales. In 1999, this division generated an 8% return with a ROCE
of 17%. Over the three years, sales volume increased by over 35%.
President and CEO of Analogic Corporation (Sales - $300M):
Halted revenue erosion in first year. In 2001, Analogic experienced the largest single year increase in
revenues from $298M to $360M with 8% increase in profit. Stock price increased from $24 on
October 18, 1999 to over $40 during a period of an overall sharp decline in the NASDAQ.
Chairman and CEO, LightLab Imaging, LLC (Current sales - $100M):
Started with an investment of $10M, the company was sold for a multiple of over three times the
initial investment three years later and was recently acquired by St. Jude’s Medical for $90M.
CEO, Siemens Medical Solutions, Inc., Health Services (Sales not disclosed but > $1.0B):
Following the acquisition, the business plunged into losses. A multi-year turnaround was executed,
an industry leading CEO hired, and today this is a profitable part of the Siemens Healthcare portfolio.
Managing Board, CEO Customer Solutions, Siemens AG, Healthcare (Sales - $13B Euro):
Following major organizational changes in Africa, Russia, Asia, and the Middle East, the business
overachieved all growth and profit targets for the last three years. Achieved industry-leading growth
in China of over 30% per year becoming the second largest contributor to absolute profit.
3
Other Activities and Achievements
Early in career, invited lecturer at meetings of the Society of Magnetic Resonance in Medicine
(including the keynote address in 1994), the Society of Magnetic Resonance Imaging, the Diagnostic
Imaging Industrial Conference, and the Conference on the Economics of Diagnostic Imaging.
Accomplishments lead to being featured in the December 1996 issue of “Diagnostic Imaging”
magazine in their cover story on “The 20 Most Influential People in Diagnostic Radiology”. Also
featured in the December 1996 issue of “Modern Health Care” in the cover article about the new
Managed Healthcare Service business.
Currently a frequent speaker on healthcare technology and business at such venues as the National
Press Club, the National Library of Medicine, the National Institute of Health, and the American
Hospital Association. Selected by the diagnostic imaging industry to provide Congressional
testimony to the House Health Sub-Committee in June of 2009 and to speak on breast cancer at the
European Parliament in 2012. In 2008, 2009, and 2010, gave the keynote lecture on technology
policy at the annual meeting of the Food and Drug Law Institute (FDLI). In 2002 became a member
of the Harvard, Kennedy School of Government, Healthcare Delivery Policy Group. Educational
seminars given at the Columbia University School of International Affairs as well as the European
School of Management and Technology on international business leadership. In 2013, gave keynote
at the Health Executive Forum in Arizona on sustainable healthcare and recently completed an article
for Arab Health Magazine summarizing a keynote speech given at this year’s Arab Health meeting in
Dubai.
4